Alcohol-free red wine inhibits isoproterenol-induced cardiac remodeling in rats by the regulation of Akt1 and protein kinase C α/β II

Journal of Nutritional Biochemistry

Volumn 20, Issue 6, 2009, Pages 418-425

  Palfi, Anita ^a   Bartha, Eva ^a   Copf, Laszlo ^a   Mark, Laszlo ^a   Gallyas Jr , Ferenc ^a   Veres, Balazs ^a   Kalman, Endre ^a   Pajor, Laszlo ^a   Toth, Kalman ^a   Ohmacht, Robert ^a   Sumegi, Balazs ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Alcohol free red wine; Cardiac fibrosis; Cardiac remodeling; Intracellular signaling pathways

Indexed keywords

ALCOHOL; ANTHOCYANIN; COLLAGEN TYPE 3; ISOPRENALINE; POLYPHENOL DERIVATIVE; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; RESVERATROL;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; CONTROLLED STUDY; DRESSLER SYNDROME; ENZYME ACTIVATION; EXPERIMENTAL RAT; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART PROTECTION; HEART SIZE; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; MALE; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; RED WINE; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANIMALS; CARDIOTONIC AGENTS; ISOPROTERENOL; MALE; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN KINASE C-ALPHA; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; VENTRICULAR REMODELING; WINE;

RATTUS;

EID: 67349156421     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2008.04.009     Document Type: Article

References (37)

1. Auger C., Al-Awwadi N., Bornet A., Rounat J.M., Gasc F., Cros G., et al. Catechins and procyanidins in Mediterranean diets. Food Res Intern 37 (2004) 233-245
2. Corder R., Mullen W., Khan N.Q., Marks S.C., Wood E.G., Carrier M.J., et al. Oenology: red wine procyanidins and vascular health. Nature 444 (2006) 566
3. Palfi A., Toth A., Hanto K., Deres P., Szabados E., Szereday Z., et al. PARP Inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3 beta pathway. J Mol Cell Cardiol 41 (2006) 149-159
4. See F., Thomas W., Way K., Tzanidis A., Kompa A., Lewis D., et al. p38 Mitogen-Activated Protein Kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat. J Am Coll Cardiol 44 (2004) 1679-1689
5. Reynolds K., Lewis L.B., Nolen J.D., Kinney G.L., Sathya B., and He J. Alcohol consumption and risk of stroke. A metaanalysis. JAMA 289 (2003) 579-588
6. Diebolt M., Germain L., Auger F.A., and Andriantsitohaina R. Mechanism of potentiation by polyphenols of contraction in human vein-engineered media. Am J Physiol Heart Circ Physiol 288 (2005) 2918-2924
7. Das D.K., Sato M., Ray P.S., Maulik G., Engelman R.M., and Bertelli A.A. Cardioprotection of red wine: role of polyphenolic antioxidants. Drugs Exp Clin Res 25 (1999) 115-120
8. Hung L.M., Su M.J., Chu W.K., Chiao C.W., Chan W.F., and Chen J.K. The protective effect of resveratrols on ischemia-reperfusion injuries of rat hearts is correlated with antioxidant efficacy. Br J Pharmacol 135 (2002) 1627-1633
9. Nikfardjam M.S.P., Mark L., Avar P., Figler M., and Ohmacht R. Polyphenols, anthocyanins, and trans-resveratrol in red wines from the Hungarian Villany region. Food Chem 98 (2006) 453-462
10. Lagouge M., Argmann C., Gerhart-Hines Z., Meziane H., Lerin C., Daussin F., et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127 (2006) 1109-1122
11. Koo S.H., and Montminy M. In vino veritas: a tale of two sirt1s?. Cell 127 (2006) 1091-1093
12. Li H.L., Wang A.B., Huang Y., Liu D.P., Wei C., Williams G.M., et al. Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways. Free Radic Biol Med 38 (2005) 243-257
13. Wu J.M., Wang Z.R., Hsieh T.C., Bruder J.L., Zou J.G., and Huang Y.Z. Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine. Int J Mol Med 8 (2001) 3-17
14. Hung L.M., Chen J.K., Huang S.S., Lee R.S., and Su M.J. Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovasc Res 473 (2000) 549-555
15. Dernek S., Ikizler M., Erkasap N., Ergun B., Koken T., Yilmaz K., et al. Cardioprotection with resveratrol pretreatment: improved beneficial effects over standard treatment in rats after global ischemia. Scand Cardiovasc J 38 (2004) 245-254
16. Song L., Xu M., Lopes-Virella M.F., and Huanq Y. Quercetin inhibits Matrix Metalloproteinase-1 expression in human vascular endothelial cells through extracellular signal-regulated kinase. Arch Biochem Biophysics 391 (2001) 72-78
17. Sato M., Bagchi D., Tosaki A., and Das D.K. Grape seed proanthocyanidin reduces cardiomyocyte apoptosis by inhibiting ischaemia/reperfusion-induced activation of JNK-1 and C-Jun. Free Radic Biol Med 31 (2001) 729-737
18. Sutherland B.A., Rahman R.M.A., and Appleton I. Mechanisms of action of green tea catechins, with a focus on ischemia-induced neurodegeneration. J Nutr Biochem 17 (2006) 291-306
19. Castelli N.P. How many drinks a day?. JAMA 242 (1979) 2000-2002
20. Stampfer M.J., Colditz G.A., and Willet W.C. A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Eng J Med 319 (1988) 267-273
21. Tibblin G., Wilhemsen L., and Werko L. Risk factors for myocardial infarction and death due to ischemic heart disease and other causes. Am J Cardiol 35 (1975) 522-524
22. Chan M.M., Mattiacci J.A., Hwang H.S., Shah A., and Fonq D. Synergy between ethanol, and grape polyphenols, quercetin, and resveratrol, in the inhibition of the inducible nitric oxide synthase pathway. Biochem Pharmacol 60 (2000) 1539-1548
23. Lim J.Y., Park S.J., Hwang H.Y., Park E.J., Nam J.H., Kim J., et al. TGF-b1 induces cardiac hypertrophic responses via PKC-dependent ATF-2 activation. J Mol Cell Cardiol 39 (2005) 627-636
24. Sugden H.P. Ras, Akt, and mechanotransduction in the cardiac myocyte. Circ Res 93 (2003) 1179-1192
25. Bogoyevitch M.A. Signalling via stress-activated mitogen-activated protein kinases in the cardiovascular system. Cardiovasc Res 45 (2000) 826-842
26. Grimm D., Elsner D., Schunkert H., Pfeifer M., Griese D., Bruckschlegel G., et al. Development of heart failure following isoproterenol administration in the rat: role of the renin-angiotensin system. Cardiovasc Res 37 (1998) 91-100
27. Das S., Fraga C.G., and Das D.K. Cardioprotective effect of resveratrol via HO-1 expression involves p38 map kinase and PI-3-kinase signaling, but does not involve NFkappaB. Free Radic Res 40 (2006) 1066-1075
28. Das S., Tosaki A., Bagchi D., Maulik N., and Das D.K. Potentiation of a survival signal in the Ischemic Heart by Resveratrol through p38 Mitogen-Activated Protein Kinase/Mitogen- and Stress-Activated Protein Kinase 1/cAMP Response Element-Binding Protein Signaling. J Pharmacol Exp Ther 317 (2006) 980-988
29. Goh S.S.C., Woodman O.L., Pepe S., Cao A.H., Qin C., and Ritchie R.H. The red wine antioxidant resveratrol prevents cardiomyocyte injury following ischemia-reperfusion via multiple sites and mechanisms. Antioxidants and Redox Signaling 9 (2007) 101-113
30. Zamin L.L., Dillenburg-Pilla P., and Argenta-Comiran R. Protective effect of resveratrol against oxygen-glucose deprivation in organotypic hippocampal slice cultures: Involvement of PI3-K pathway. Neurobiol Dis 24 (2006) 170-182
31. Muslin AJ, DeBosch B. Role of Akt in cardiac growth and metabolism. Novartis Found Symp. 2006;274:118-26, 126-31, 152-5, 272-6.
32. Kunishige M., Kijima Y., Sakai T., Akutagawa O., Matsuo A., Nishibe A., et al. Transient enhancement of oxidant stress and collagen turnover in patients with acute worsening of congestive heart failure. Circ J 71 (2007) 1893-1897
33. 2 regulates the angiogenic phenotype via PTEN oxidation. J Biol Chem 280 (2005) 16916-16924
34. Veres B., Gallyas Jr. F., Varbiro G., Berente Z., Osz E., Szekeres G., et al. Decrease of the inflammatory response and induction of the Akt/protein kinase B pathway by poly-(ADP-ribose) polymerase 1 inhibitor in endotoxin-induced septic shock. Biochem Pharmacol 65 (2003) 1373-1382
35. Tapodi A., Debreceni B., Hanto K., Bognar Z., Wittmann I., Gallyas Jr. F., et al. Pivotal role of Akt activation in mitochondrial protection and cell survival by poly(ADP-ribose)polymerase-1 inhibition in oxidative stress. J Biol Chem 280 (2005) 35767-35775
36. Kovacs K., Toth A., Deres P., Kalai T., Hideg K., Gallyas Jr. F., et al. Critical role of PI3-kinase/Akt activation in the PARP inhibitor induced heart function recovery during ischemia-reperfusion. Biochem Pharmacol 71 (2006) 441-452
37. Lefèvre J., Michaud S.E., Haddad P., Dussault S., Ménard C., Groleau J., et al. Moderate consumption of red wine (Cabernet Sauvignon) improves ischemia-induced neovascularization in ApoE-deficient mice: effect on endothelial progenitor cells and nitric oxide. FASEB J 21 (2007) 3845-3852